Impact of postnatal dexamethasone on psychotomimetic effects of MK-801 measured on adult rats.
Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 6
Abstract
The present study investigates the impact of dexamethasone (DEX) given in tapering doses in the postnatal period on MK-801-induced locomotor activity and MK-801-evoked deficits of sensorimotor gating of adult rats (60 days old). It has been found that DEX given on postnatal day 1 (0.5 microg/g), day 2 (0.3 microg/g) and day 3 (0.1 microg/g) has no effects on spontaneous locomotor activity and does not influence locomotion observed after MK-801 given in a dose of 0.2 and 0.4 mg/kg. Postnatal DEX treatment did not alter the efficacy of sensorimotor gating and its deficits evoked by MK-801 at a dose of 0.2 and 0.4 mg/kg. However, a slight increase in the amplitude of startle reaction has been noted in DEX-treated animals. In conclusion, the results of the present study indicate that DEX given postnatally in tapering doses, although pharmacologically effective (decrease in a gain of body and brain weight), has no potential pro-psychotic effects and does not influence pharmacologically induced psychoses by MK-801. The above data indicate that apart from other side effects, the therapeutic application of DEX in the postnatal period is possibly safe in terms of the risk for developing schizophrenia.
Authors and Affiliations
Krzysztof Wędzony, Katarzyna Markowicz-Kula, Agnieszka Chocyk, Aleksandra Przyborowska, Marzena Maćkowiak
Keywords
Related Articles
- EP ID EP129135
- DOI -
- Views 79
- Downloads 0
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.
In Parkinson's disease (PD), prolonged exposure to L-3,4-dihydroxyphenylalanine (L-DOPA) results in motor fluctuations, such as the on-off phenomenon, and L-DOPA-induced dyskinesia. Previously, we found that activation o...
Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance.
Background: No previous clinical study has been designed to assess the additive effect of metformin and a fibrate on lymphocyte secretory function. The aim of our study was to investigate whether metformin produces any e...
Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation.
Background: Inhibiting the action of proprotein convertase subtilisin/kexin type 9 (PCSK9) on the low-density lipoprotein receptor (LDLR) has emerged as a novel therapeutic target for hypercholesterolemia. Here we invest...
Impact of aromatic substitution on the anticonvulsant activity of new N-(4-arylpiperazin-1-yl)-alkyl-2-azaspiro[4,5]decane-1,3-dione derivatives.
A series of N-[(4-arylpiperazin-1-yl)-alkyl]-2-azaspiro[4.5]decane-1,3-dione derivatives were synthesized and evaluated for their anticonvulsant and neurotoxic properties. The main modifications to that series of compoun...
Treatment of dyslipidemia in patients with diabetes mellitus.
The article reviews the key aspects of pathophysiology of diabetic dyslipidemia, its treatment and associated risk of cardiovascular complications. It examines the difference in lipidmetabolism between type 1 and type 2...